» Articles » PMID: 21184581

Factors Associated with Experiences of Genetic Discrimination Among Individuals at Risk for Huntington Disease

Overview
Date 2010 Dec 25
PMID 21184581
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to identify factors that are associated with experiencing genetic discrimination (GD) among individuals at risk for Huntington disease (HD). Multivariable logistic regression analysis was used to examine factors associated with experiencing GD in data from a cross-sectional, self-report survey of 293 individuals at risk for HD. The study sample comprised 167 genetically tested respondents, and 66 who were not tested (80% response rate). Overall, individuals who learn they are at risk for HD at a younger age (OR = 3.1; 95% CI: 1.5-6.2; P = 0.002), are mutation-positive (OR = 2.8; 95% CI: 1.4-6.0; P = 0.006), or are highly educated (OR = 2.7; 95% CI: 1.4-5.1; P = 0.002) are more likely to experience GD, particularly in insurance, family, and social settings. Further, younger age was associated with discrimination in insurance (OR = 0.97; 95% CI: 0.94-1.00; P = 0.038). This study provides evidence that some people who are at risk for HD were more likely to experience GD than others. Individuals who learned they are at risk for HD at a younger age and those who are mutation-positive were more likely to experience GD, particularly in insurance, family, and social settings. Younger individuals were more likely to experience discrimination in the insurance setting. Overall, highly educated individuals were also more likely to report discrimination. These results provide direction for clinical and family discussions, counseling practice, and policy aimed at mitigating experiences of GD.

Citing Articles

Impact of Huntington Disease Gene-Positive Status on Pre-Symptomatic Young Adults and Recommendations for Genetic Counselors.

Gong P, Fanos J, Korty L, Siskind C, Hanson-Kahn A J Genet Couns. 2016; 25(6):1188-1197.

PMID: 27103420 DOI: 10.1007/s10897-016-9951-z.


Experiences of predictive testing in young people at risk of Huntington's disease, familial cardiomyopathy or hereditary breast and ovarian cancer.

MacLeod R, Beach A, Henriques S, Knopp J, Nelson K, Kerzin-Storrar L Eur J Hum Genet. 2013; 22(3):396-401.

PMID: 23860040 PMC: 3925271. DOI: 10.1038/ejhg.2013.143.


Citizens' perspectives on personalized medicine: a qualitative public deliberation study.

Bombard Y, Abelson J, Simeonov D, Gauvin F Eur J Hum Genet. 2013; 21(11):1197-201.

PMID: 23340511 PMC: 3798829. DOI: 10.1038/ejhg.2012.300.


Genetic testing in psychiatry: a review of attitudes and beliefs.

Lawrence R, Appelbaum P Psychiatry. 2011; 74(4):315-31.

PMID: 22168293 PMC: 3285424. DOI: 10.1521/psyc.2011.74.4.315.

References
1.
Taylor S, Treloar S, Barlow-Stewart K, Stranger M, Otlowski M . Investigating genetic discrimination in Australia: a large-scale survey of clinical genetics clients. Clin Genet. 2008; 74(1):20-30. DOI: 10.1111/j.1399-0004.2008.01016.x. View

2.
Watson J, Scarinci I, Klesges R, Slawson D, Beech B . Race, socioeconomic status, and perceived discrimination among healthy women. J Womens Health Gend Based Med. 2002; 11(5):441-51. DOI: 10.1089/15246090260137617. View

3.
Forrest K, Simpson S, Wilson B, van Teijlingen E, McKee L, Haites N . To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet. 2003; 64(4):317-26. DOI: 10.1034/j.1399-0004.2003.00142.x. View

4.
Hadley D, Jenkins J, Dimond E, Nakahara K, Grogan L, Liewehr D . Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch Intern Med. 2003; 163(5):573-82. DOI: 10.1001/archinte.163.5.573. View

5.
Bower M, McCarthy Veach P, Bartels D, LeRoy B . A survey of genetic counselors' strategies for addressing ethical and professional challenges in practice. J Genet Couns. 2003; 11(3):163-86. DOI: 10.1023/a:1015275022199. View